Company intelligence / Profile preview

Invus

New York, New York, United Statesinvus.com ↗

Ownership: Private
Development stage: Other

Overview

Invus is a global private equity and venture capital investment firm founded in 1985. It manages over $10 billion in evergreen capital and invests across consumer, technology, and life sciences sectors. In healthcare/life sciences specifically, it has backed numerous biotech companies at various stages from early growth to public markets[1][2][3][4]. Its approach is long-term and high-touch with both private and public equity strategies.

Modalities: Small moleculeMonoclonal antibodymRNA-based drugsCell therapy
Industry: Investors

Partnerships

Polaris PartnersVersant VenturesFidelity Management & Research CompanyRedmile Group

Beyond the preview

Go deeper on Invus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invus.

Explore the full profile